Watchlist Price Alert

Moleculin Biotech Inc. (MBRX)

NASDAQ: MBRX · Real-Time Price · USD

0.66

-0.03 (-3.68%)

At close: Jun 17, 2025, 3:08 PM

Moleculin Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-21.76M	-29.77M	-29.02M	-15.89M	-17.36M	-13.21M	-11.88M	-9.8M	-3.93M
Depreciation & Amortization	126K	127K	130K	164K	200K	199K	68K	18K	6.16K
Stock-Based Compensation	1.73M	1.98M	2.27M	2.37M	1.68M	1.54M	1.14M	707K	411.47K
Other Working Capital	699K	1.22M	-507K	803K	983K	-3.05M	1.17M	131K	40.87M
Other Non-Cash Items	-4.18M	1.94M	-1.24M	96K	85K	476K	-3.15M	2.6M	423.8K
Deferred Income Tax	n/a	n/a	n/a	-6.73M	-2.34M	-4.06M	n/a	-1.39M	n/a
Change in Working Capital	231K	1.62M	224K	1.04M	-41K	-2.14M	1.61M	542K	-256.18K
Operating Cash Flow	-23.86M	-24.1M	-27.64M	-18.95M	-17.77M	-17.2M	-12.2M	-7.32M	-3.76M
Capital Expenditures	-13K	-124K	-67K	-19K	-376K	-52K	-417K	-28K	-21.47K
Cash Acquisitions	n/a	n/a	n/a	n/a	2K	1K	n/a	n/a	-99.64K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	2.00	n/a	n/a	n/a	n/a
Investing Cash Flow	-13K	-124K	-67K	-19K	-374K	-51K	-417K	-28K	-121.11K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-304.94K
Common Stock Repurchased	n/a	n/a	-23	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-25K	485K	-23K	40K	-12K	1.56M	20K	3.99M	-61
Financial Cash Flow	4.63M	4.65M	-23K	74.72M	22.55M	20.85K	12.04M	10.06M	8.87M
Net Cash Flow	-19.27M	-19.59M	-27.76M	55.73M	4.44M	3.6M	-580K	2.71M	4.98M
Free Cash Flow	-23.88M	-24.23M	-27.71M	-18.97M	-18.15M	-17.25M	-12.62M	-7.35M	-3.79M